exp3174 has been researched along with Debility in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abadir, PM; Anders, NM; Bichara, MD; Buta, B; Carey, RM; de Cabo, R; Ferrucci, L; Gabrawy, MM; Khadeer, M; Kwak, MJ; Le, A; Lee, JL; Ma, L; Marx, R; Moaddel, R; Nidadavolu, L; Rudek, MA; Siragy, HM; Tian, J; Walston, JD; Westbrook, R; Wu, Y; Xue, QL; Yang, H; Yenokyan, G; Zhang, C | 1 |
1 trial(s) available for exp3174 and Debility
| Article | Year |
|---|---|
Serum Concentrations of Losartan Metabolites Correlate With Improved Physical Function in a Pilot Study of Prefrail Older Adults.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Frailty; Imidazoles; Losartan; Pilot Projects; Tetrazoles | 2022 |